Research programme: nonviral gene therapies - Takeda Pharmaceutical
Alternative Names: Research programme: gene therapies - Takeda PharmaceuticalLatest Information Update: 06 Sep 2021
At a glance
- Originator Takeda
- Class Gene therapies; Hepatoprotectants
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Liver disorders